2020 election brewing ‘perfect storm’ for drug-pricing reform, analyst says

(By Alia Paavola for Becker’s Hospital Review)

With President Donald Trump and Democrats both seeking healthcare policy wins ahead of the 2020 presidential election, Congress will likely pass drug pricing legislation by the end of the year, according to an RBC Capital Markets investors note cited by CNBC.   Continue reading article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.